FONR - Fonar Corporation

https://www.fonar.com

Momentum: Bearish

Recent News

FONAR's Stock Advances 5% in Three Months: Key Trends Ahead

Zacks Commentary • 5 days, 22 hours ago • score: 0.38

FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.

Bullish

FONR Stock Rises Following Q3 Earnings on Higher Net Income

Zacks Commentary • 3 months, 3 weeks ago • score: 0.34

FONAR Corporation's Q3 fiscal 2025 results show higher net income and revenue growth, driven by record MRI scan volumes and strong performance of its HMCA unit.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

FONAR Corporation is engaged in the research, development, production, and marketing of Magnetic Resonance Imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company is headquartered in Melville, New York.

52W High

$17.98

52W Low

$12.00

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.97

Valuation

Attractive

As of 2025-03-31 (Overview)

Trailing P/E (<15 better)

12.48

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

3.61

EV/Revenue (<3 favorable)

0.81

P/S (TTM) (<3 favorable)

0.95

P/B (<3 favorable)

0.57

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

5.30%

Institutions (25–75% balanced)

47.24%

Shares Outstanding

6,168,500

Float

5,659,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

1999-03-18

Income & Growth

Profitability: Weak

As of 2025-03-31 (Overview)

Revenue (TTM)

103,018,000

Gross Profit (TTM)

42,478,000

EPS (TTM)

1.25

Profit Margin (>10% good)

0.08%

Operating Margin (TTM) (higher better)

0.14%

ROE (TTM) (>15% strong)

0.07%

EPS YoY (Quarterly) (>10% good)

0.37

Revenue YoY (Quarterly) (>8% good)

0.06

Momentum

Bearish momentum

Value

0.0832

0.0827

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025